NEWS

UC San Diego News Center

MENU
Study to Examine Possible Effects of Cannabis Compound for Common Movement Disorder

Researchers at University of California School of Medicine are preparing to launch a novel clinical trial to examine the safety, efficacy and pharmacological properties of cannabis as a potential treatment for adults with essential tremor (ET). Currently, ET is treated using repurposed medications originally developed for high blood pressure or seizures.

Study to Examine Possible Effects of Cannabis Compound for Common Movement Disorder

https://ucsdnews.ucsd.edu/news_uploads/2018_09_18_cannabis_2_leaf_pixabay.jpg
https://ucsdnews.ucsd.edu/pressrelease/study_to_examine_possible_effects_of_cannabis_compound_for_common_movement_disorder
Study to Examine Possible Effects of Cannabis Compound for Common Movement Disorder
Researchers at University of California School of Medicine are preparing to launch a novel clinical trial to examine the safety, efficacy and pharmacological properties of cannabis as a potential treatment for adults with essential tremor (ET). Currently, ET is treated using repurposed medications originally developed for high blood pressure or seizures.
https://ucsdnews.ucsd.edu/news_uploads/2018_09_13_rat_cerebellum_deerinck.jpg
https://ucsdnews.ucsd.edu/pressrelease/nikon_imaging_center_opens_at_uc_san_diego
Nikon Imaging Center Opens at UC San Diego
The Nikon Imaging Center, a collaborative microscopy center that provides local researchers with access to the latest imaging technologies, opened September today at the University of California San Diego.
https://ucsdnews.ucsd.edu/news_uploads/2018_09_13_sirius_red_casp2_karin.jpg
https://ucsdnews.ucsd.edu/pressrelease/caspase_2_enzyme_inhibition_shows_promise_for_ameliorating_fatty_liver_disease
Caspase-2 Enzyme Inhibition Shows Promise for Ameliorating Fatty Liver Disease
Researchers at University of California San Diego School of Medicine have discovered using mice and human clinical specimens, that caspase-2, a protein-cleaving enzyme, is a critical driver of non-alcoholic steatohepatitis (NASH), a chronic and aggressive liver condition. By identifying caspase-2’s critical role, they believe an inhibitor of this enzyme could provide an effective way to stop the pathogenic progression that leads to NASH — and possibly even reverse early symptoms.
https://ucsdnews.ucsd.edu/news_uploads/2018_09_12_infant_bioprint_UCSDHealth.jpg
https://ucsdnews.ucsd.edu/pressrelease/researchers_develop_biometric_tool_for_newborn_fingerprinting
Researchers Develop Biometric Tool for Newborn Fingerprinting
Researchers at the University of California San Diego say they have dramatically advanced the science of biometric identification, creating a novel technology that can capture the fingerprints of infants and children, even on the first day of birth.